InfuSystem
INFU
A$9.04
Share price
-1.83%
Change (1 day)
-11.84%
Change (1 year)
Categories
Revenue for InfuSystem (INFU)
Revenue in 2025 (TTM): A$0.21 Billion
According to InfuSystem's latest financial reports the company's current revenue (TTM 
) is A$0.21 Billion. In 2024 the company made a revenue of A$0.21 Billion an increase over the revenue in the year 2023 that were of A$0.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for InfuSystem from 2008 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | A$0.21 B | -2.41% |
| 2024 | A$0.21 B | 17.44% |
| 2023 | A$0.18 B | 14.31% |
| 2022 | A$0.16 B | 14.37% |
| 2021 | A$0.14 B | 11.5% |
| 2020 | A$0.12 B | 9.32% |
| 2019 | A$0.11 B | 21.57% |
| 2018 | A$95.3 M | 4.68% |
| 2017 | A$91.04 M | -6.91% |
| 2016 | A$97.8 M | -0.13% |
| 2015 | A$97.92 M | 20.54% |
| 2014 | A$81.24 M | 16.35% |
| 2013 | A$69.82 M | 23.34% |
| 2012 | A$56.6 M | 6.24% |
| 2011 | A$53.28 M | 14.61% |
| 2010 | A$46.49 M | 7.19% |
| 2009 | A$43.37 M | -13.59% |
| 2008 | A$50.19 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 CorVel Corporation
CRVL | A$1.37 B | 550.95% | 🇺🇸 USA |
 Premier PINC | A$1.68 B | 699.57% | 🇺🇸 USA |
 Biolase
BIOL | A$70.54 M | -66.55% | 🇺🇸 USA |
 DexCom DXCM | A$6.35 B | 2,914.93% | 🇺🇸 USA |